Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oventus Medical - Notice of General Meeting/Proxy Form (ASX:OVN)

To view the Notice of General Meeting & Explanatory Statement. download the attached PDF.

MMJ Group Holdings - Harvest One Loan Update (ASX:MMJ)

MMJ is pleased to advise that, in continued support of Harvest One Cannabis Inc.’s ("HVT" or "Harvest One") (TSX-V: HVT; OTCQX: HRVOF) previously-announced strategic review...read more

MMJ Group Holdings - Embark Health Investment Update (ASX:MMJ)

In the attached release Embark Health Inc. ("Embark" or the "Company") announced that they have entered into a binding letter of intent dated June 29, 2020 with Mesa Exploration ...read more

Elixinol Global - Notice of Annual General Meeting & Proxy Form (ASX:EXL)

Elixinol Global Limited (Elixinol Global or the Company) (ASX:EXL; OTC:ELLXF) is pleased to announce that it will be hosting its 2020 Annual General Meeting via live webcast at 10.30am (Sydney Time)...read more

MMJ Group Holdings Announces Update on MMJs investment in Harvest One (ASX:MMJ)

On 26 June 2020, Harvest One Cannabis Inc. ("HVT" or "Harvest One" or the “Company”) (TSX-V: HVT; OTCQX: HRVOF) has announced a number of key initiatives: a) Sale ...read more

Immutep Completes Recruitment for Part A of TACTI-002 trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, is...read more

Immutep receives A$1,437,826 R&D Tax Incentive (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or the “Company”), is pleased to announce that it has received a A$1,437,826 cash rebate from the Australian Federal Gover...read more

Noxopharm Announces COVID-19 Trial Program to Commence in Europe (ASX:NOX)

NOX announces commencement of its NOXCOVID clinical program with a planned Phase 1 trial in Europe. This action is designed to provide important safety data and proof-of-principle of Veyonda as a po...read more

Oventus Medical - Appendix 3B (ASX:OVN)

To view the Proposed issue of +securities, download the attached PDF.

Oventus Medical - Cleansing Notice (ASX:OVN)

Oventus Medical Limited (the Company) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (Corporations Act) as follows: 1. The Company has issued 364,584 fully paid ordinary...read more

Oventus Medical - Appendix 3G (ASX:OVN)

To view the Notification of issue, conversion or payment up of equity +securities, download the attached PDF.

Oventus Medical - Appendix 2A (ASX:OVN)

To view the Application for quotation of +securities, download the attached PDF.

Oventus Medical - Issuance of Shares and Options under SPP and Placement (ASX:OVN)

Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce that it has today issued the Shares and Options under the Share Purchase Plan (SPP), the Opt...read more

Oventus Medical - Share Purchase Plan closes oversubscribed (ASX:OVN)

Obstructive Sleep Apnoea (OSA) treatment innovator, Oventus Medical Ltd (ASX: OVN) is pleased to announce that the Share Purchase Plan (SPP) announced on 1 May 2020 has successfully closed, with sub...read more

Elixinol Global - Appendix 3Y - Paul Benhaim (ASX:EXL)

In accordance with ASX Listing Rule 3.19A.2, Elixinol Global Limited (Elixinol or the Company) provides an Appendix 3Y for Mr Paul Benhaim. Mr Benhaim has entered into a margin loan facility (Loa...read more

Viewing: 1 - 15 of 200 Previous | Next